Clinical Trials Directory

Trials / Terminated

TerminatedNCT04651621

SMA Targeted Magnetic Stimulation Against Auditory Verbal Hallucinations

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
Uppsala University · Academic / Other
Sex
All
Age
18 Years – 59 Years
Healthy volunteers
Accepted

Summary

Auditory verbal hallucinations (AVH) are prevalent among patients with psychiatric disorders. Not only being highly stressful and functionally impairing, AVH often persist despite treatment. Recent attempts to treat AVH with add-on repetitive transcranial magnetic stimulation (rTMS) when targeting the temporoparietal junction (TPJ), a language node in the brain, has gained limited success. The aim of this investigation is to reduce AVH with rTMS using continous theta-burst stimulation over a novel target, the supplementary motor area (SMA), in participants with frequent AVH, while also assessing potential neurophysiological mechanisms underlying the symptom.

Conditions

Interventions

TypeNameDescription
DEVICEcontinuous theta burst stimulation over the SMAEach cTBS session consists of bursts of three pulses delivered with a rate of 50 Hz, with bursts repeated at a rate of 5 Hz for a total duration of 40 seconds, summing up to 600 pulses, 100% of motor threshold (MT) and applied over bilateral SMA. The target is located in the anterior-posterior direction over the transition between pre-SMA and SMA proper, (cortical point where a vertical line will pass through the anterior commissure). The center of a figure-of-eight coil will be placed over the target, guided with neuronavigation equipment that utilizes the anatomical brain image from the pre-cTBS scanning session.
DEVICEsham continuous theta burst stimulation over the SMAThe same stimulation parameters but a concealed sham coil will be used with only superficial magnetic stimulation to mimic the sensation of the active stimulation

Timeline

Start date
2020-11-02
Primary completion
2024-02-01
Completion
2024-02-08
First posted
2020-12-03
Last updated
2024-07-22

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT04651621. Inclusion in this directory is not an endorsement.